Novel treatment strategies in ACS patients

Session comprising selected EuroPCR 2023 Abstract submissions

Facilitators: E. Cerrato, M. Sabate

Summary

Seeking to revive your understanding on novel strategies in ACS treatment? Explore this collection of resources to get insight on optimal antithrombotic therapy in AF patients post-PCI, complete revascularisation in ACS, and early invasive approaches in high-risk NSTEMI, among other topics. 

Presentations available when logged in:

  • Optimal antithrombotic therapy in atrial fibrillation patients undergoing PCI - WOEST-3 trial
  • Complete revascularisation in ACS with multivessel disease. The CORALYS registry
  • Immediate vs. staged complete revascularisation in patients with ACS and multivessel disease
  • Very early invasive strategy vs. standard of care in higher-risk NSTEMI
  • One-year results of the BioFreedom Asian STEMI registry